Good morning, everyone, and hope you are doing well today. The aftermath of the hurricane continues to prove challenging for so many, but the Pharmalot corporate campus is back to what passes for normal. So we are brewing that familiar - and much-needed - cup of stimulation as we attempt to resume the usual routine. Although we know many in our region are unable to do so, we hope that the situation shows further signs of improvement as quickly as possible. Meanwhile, here are some tidbits to help you along. Have a good day and stay in touch...
Novartis Does Not Expect More Flu Vaccine Bans (Reuters)
J&J And Bayer's Xarelto Is OKed For Wider Use (Pharma Times)
India's Rx Price Regulator To Visit Manufacturing Plants (Business Standard)
Sanofi Considered Moving Headquarters From France (Le Journal du Dimanche)
Novartis Loses Zometa Trial And Must Pay $10M (Bloomberg News)
US-Funded Chelation Study Fails To Convince Many Doctors (Forbes)
Ameridose Compounder Extends Closure (Reuters)
Pfizer Antitrust Suit Stays In Federal Court (Courthouse News)
Rising Diabetes In China Creates $3.2B Drug Market (Bloomberg News)
Novartis Considers Investment In Malaysia (Business Times)
Walgreen Adds 'Green' Product Line As Part Of Private Label Push (Reuters)
EDITOR'S NOTE: Please check this post for updates
sunrise pic thx to benimoto on flickr
1 Comment